Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-22
DOI
10.1038/s41598-020-57707-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Mechanisms of ferroptosis
- (2016) Jennifer Yinuo Cao et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
- (2016) Erik S. Linklater et al. Oncotarget
- Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
- (2015) C. Zhou et al. ANNALS OF ONCOLOGY
- First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
- (2015) Y.-L. Wu et al. ANNALS OF ONCOLOGY
- Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers
- (2015) Zhu Luo et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
- (2015) Ondrej Fiala et al. TUMOR BIOLOGY
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
- (2014) Ki-Eun Hwang et al. EXPERIMENTAL CELL RESEARCH
- Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
- (2014) Rachid Skouta et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Necroptosis in health and diseases
- (2014) Wen Zhou et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
- (2013) J Chen et al. Cell Death & Disease
- Statins Reduce Melanoma Development and Metastasis through MICA Overexpression
- (2013) Christine Pich et al. Frontiers in Immunology
- Understanding synergy
- (2012) Nori Geary AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Oncosis: An important non-apoptotic mode of cell death
- (2012) Priya Weerasinghe et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Calpains as potential anti-cancer targets
- (2011) Ludovic Leloup et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
- (2010) Danny R. Youlden et al. Journal of Thoracic Oncology
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Predicting Response to EGFR Inhibitors in Metastatic Colorectal Cancer: Current Practice and Future Directions
- (2010) V. Shankaran et al. ONCOLOGIST
- Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells
- (2009) S Agarwal et al. BRITISH JOURNAL OF CANCER
- Autocrine amplification loop in statin-induced apoptosis of human melanoma cells
- (2009) C Minichsdorfer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells
- (2009) Evelyn Sieczkowski et al. INTERNATIONAL JOURNAL OF CANCER
- Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
- (2009) In Hae Park et al. INVESTIGATIONAL NEW DRUGS
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2009) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- A Sweet New Role for EGFR in Cancer
- (2008) Jeffrey A. Engelman et al. CANCER CELL
- Rhabdomyolysis Resulting from Pharmacologic Interaction Between Erlotinib and Simvastatin
- (2008) Muthu Veeraputhiran et al. Clinical Lung Cancer
- Câncer de pulmão: histologia, estádio, tratamento e sobrevida
- (2008) Fabiola Trocoli Novaes et al. Jornal Brasileiro de Pneumologia
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started